Syringin prevents cardiac hypertrophy induced by pressure overload through the attenuation of autophagy

  • Authors:
    • Fangfang Li
    • Ning Zhang
    • Qingqing Wu
    • Yuan Yuan
    • Zheng Yang
    • Mengqiao Zhou
    • Jinxiu Zhu
    • Qizhu Tang
  • View Affiliations

  • Published online on: December 8, 2016     https://doi.org/10.3892/ijmm.2016.2824
  • Pages: 199-207
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Syringin, extracted from Eleutherococcus senticosus, is a major biologically active component of Chinese herbs. Studies have certified the multiple pharmacological properties of syringin. However, the role of syringin in cardiac hypertrophy and the mechanisms involved remain unclear. In this study, aortic banding was performed on mice in order to induce cardiac hypertrophy, and the animals were then treated with syringin for 7 weeks. Echocardiography and catheter-based measurements of hemodynamic parameters were performed to evaluate cardiac function at 8 weeks following aortic banding. Morphological and pathological changes were also evaluated. Alterations in the expression levels of hypertrophy- and autophagy-related markers [atrial natriuretic peptide (ANP), β-myosin heavy chain MHC), α-MHC, B-type natriuretic peptide (BNP), autophagy-related gene (ATG)5, ATG7, beclin 1, light chain 3 (LC3) A/B] were measured by reverse transcription-quantitative PCR and western blot analysis. The effects of syringin on cardiomyocyte hypertrophy induced by angiotensin II in H9c2 cells were also investigated. The results revealed that syringin attenuated cardiac hypertrophy induced by aortic banding via the activation of AMP-activated protein kinase α (AMPKα) and autophagy-related signaling pathways. Thus, we our data suggest that syringin possesses therapeutic potential to attenuate the progression of cardiac hypertrophy.
View Figures
View References

Related Articles

Journal Cover

January-2017
Volume 39 Issue 1

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li F, Zhang N, Wu Q, Yuan Y, Yang Z, Zhou M, Zhu J and Tang Q: Syringin prevents cardiac hypertrophy induced by pressure overload through the attenuation of autophagy. Int J Mol Med 39: 199-207, 2017
APA
Li, F., Zhang, N., Wu, Q., Yuan, Y., Yang, Z., Zhou, M. ... Tang, Q. (2017). Syringin prevents cardiac hypertrophy induced by pressure overload through the attenuation of autophagy. International Journal of Molecular Medicine, 39, 199-207. https://doi.org/10.3892/ijmm.2016.2824
MLA
Li, F., Zhang, N., Wu, Q., Yuan, Y., Yang, Z., Zhou, M., Zhu, J., Tang, Q."Syringin prevents cardiac hypertrophy induced by pressure overload through the attenuation of autophagy". International Journal of Molecular Medicine 39.1 (2017): 199-207.
Chicago
Li, F., Zhang, N., Wu, Q., Yuan, Y., Yang, Z., Zhou, M., Zhu, J., Tang, Q."Syringin prevents cardiac hypertrophy induced by pressure overload through the attenuation of autophagy". International Journal of Molecular Medicine 39, no. 1 (2017): 199-207. https://doi.org/10.3892/ijmm.2016.2824